Effect of long-term angiotensin-converting enzyme inhibition on endothelial function in patients with the insulin-resistance syndrome | ORKG Ask

We use cookies to provide a better user experience.

Data Protection

Related items

Effect of Long-Term Angiotensin-Converting Enzyme Inhibition on Endothelial Function in Patients with the Insulin-Resistance Syndrome

P. J. Bijlstra
P. Smits
J. A. Lutterman
Th. Thien

October 2016

Summary: Cardiovascular risk factors such as hyperten sion, diabetes, and dyslipemia are associated ...

Effects of angiotensin II receptor inhibition on insulin-induced endothelial dysfunction in humans.

G. Arcaro
TROMBETTA, Maddalena
A. Calì
BIFARI, Francesco
A. Lechi
M. Muggeo
BONORA, Enzo
R. C. Bonadonna

January 2003

Effects of angiotensin II receptor inhibition on insulin-induced endothelial dysfunction in humans

Effects of ACE inhibition and AT(1)-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients

VELİOĞLU ÖĞÜNÇ, AYLİZ
YAVUZ, DİLEK
HAKLAR, GONCAGÜL
KOÇ, MEHMET

September 2003

Objective Disturbed endothelial function is closely associated with hyperinsulinaemia and insulin re...

NO-dependent endothelial dysfunction in type II diabetes is aggravated by dyslipidemia and hypertension, but can be restored by angiotensin-converting enzyme inhibition and weight loss

Nevelsteen, Ines
Van den Bergh, An
Van der Mieren, Gerry
Vanderper, Annelies
Mubagwa, Kanigula
Bult, Hidde
Herijgers, Paul

January 2013

Insulin resistance, dyslipidemia and hypertension are independent mediators of endothelial dysfuncti...

Tissue availability of insulin-like growth factor I is inversely related to insulin resistance in essential hypertension: effects of angiotensin converting enzyme inhibition

Laviades, C. (Concepción)
Gil, M.J. (María José)
Monreal, J.I. (José Ignacio)
Gonzalez, A. (Arantxa)
Diez-Martinez, J. (Javier)

January 1998

Background: The insulin-like growth factor I possesses biologic actions that resemble those of insul...

The relevance of tissue angiotensin-converting enzyme:Manifestations in mechanistic and endpoint data

Dzau, VJ
Bernstein, K
Celermajer, D
Cohen, J
Dahlof, B
Deanfield, J
Diex, J
Drexler, H
Ferrari, R
van Gilst, W
Hansson, L
Hornig, B
Husain, A
Johnston, C
Lazar, H
Pepine, C
Rabelink, T
Remme, W
Ruilope, L
Ruzicka, M
Schunkert, H
Swedberg, K
Unger, T
Vaughan, D
Weber, M

November 2001

Angiotensin-converting enzyme (ACE) is primarily localized (> 90%) in various tissues and organs,...

Supplementary Material for: NO-Dependent Endothelial Dysfunction in Type II Diabetes Is Aggravated by Dyslipidemia and Hypertension, but Can Be Restored by Angiotensin-Converting Enzyme Inhibition and Weight Loss

Nevelsteen I. (4141810)
Van den Bergh A. (4141816)
Van der Mieren G. (4141813)
Vanderper A. (4141807)
Mubagwa K. (4141819)
Bult H. (4141804)
Herijgers P. (3696670)

October 2013

<b><i>Aims:</i></b> Insulin resistance, dyslipidemia and hypertension are independent mediators of e...

NO-dependent endothelial dysfunction in type II diabetes is aggravated by dyslipidemia and hypertension, but can be restored by angiotensin-converting enzyme inhibition and weight loss

Nevelsteen, Ines
Van den Bergh, An
Van der Mieren, Gerry
Vanderper, Annelies
Mubagwa, Kanigula
Bult, Hidde
Herijgers, Paul

January 2013

Insulin resistance, dyslipidemia and hypertension are independent mediators of endothelial dysfuncti...

Tissue availability of insulin-like growth factor I is inversely related to insulin resistance in essential hypertension: effects of angiotensin converting enzyme inhibition

Laviades, C. (Concepción)
Gil, M.J. (María José)
Monreal, J.I. (José Ignacio)
Gonzalez, A. (Arantxa)
Diez-Martinez, J. (Javier)

January 1998

Background: The insulin-like growth factor I possesses biologic actions that resemble those of insul...

The relevance of tissue angiotensin-converting enzyme:Manifestations in mechanistic and endpoint data

Dzau, VJ
Bernstein, K
Celermajer, D
Cohen, J
Dahlof, B
Deanfield, J
Diex, J
Drexler, H
Ferrari, R
van Gilst, W
Hansson, L
Hornig, B
Husain, A
Johnston, C
Lazar, H
Pepine, C
Rabelink, T
Remme, W
Ruilope, L
Ruzicka, M
Schunkert, H
Swedberg, K
Unger, T
Vaughan, D
Weber, M

November 2001

Angiotensin-converting enzyme (ACE) is primarily localized (> 90%) in various tissues and organs,...

Supplementary Material for: NO-Dependent Endothelial Dysfunction in Type II Diabetes Is Aggravated by Dyslipidemia and Hypertension, but Can Be Restored by Angiotensin-Converting Enzyme Inhibition and Weight Loss

Nevelsteen I. (4141810)
Van den Bergh A. (4141816)
Van der Mieren G. (4141813)
Vanderper A. (4141807)
Mubagwa K. (4141819)
Bult H. (4141804)
Herijgers P. (3696670)

October 2013

<b><i>Aims:</i></b> Insulin resistance, dyslipidemia and hypertension are independent mediators of e...